Lung cancer risk stratification using methylation profile in the oral epithelium

Abstract

Background

Assuming that the entire airway is affected by the same inhaled carcinogen, similar molecular alterations may occur in the lung and oral cavity. Thus, we hypothesized that DNA methylation profiles in the oral epithelium may be a promising biomarker for lung cancer risk stratification.

Methods

A methylation-specific polymerase chain reaction was performed on oral epithelium from 16 patients with lung cancer and 32 controls without lung cancer. Genes showing aberrant methylation profiles in the oral epithelium were compared between patients and controls.

Results

The analysis revealed that HOXD11 and PCDHGB6 were methylated more frequently in patients than in controls (p = 0.0055 and p = 0.0247, respectively). Combined analyses indicated that 8 of 16 (50%) patients and 3 of 32 (9.4%) controls showed DNA methylation in both genes (p = 0.0016). Among the population limited to current and former smokers, 6 of 11 (54.5%) patients showed methylation in both genes, compared to 1 of 17 (5.9%) controls (p = 0.0037). In a subgroup analysis limited to the population above 50-years old, 8 of 16 (50%) patients and 2 of 16 (12.5%) controls showed methylation in both genes (p = 0.0221).

Conclusions

The results of this study indicate that specific gene methylation in the oral epithelium might be a promising biomarker for lung cancer risk assessment, especially among smokers. Risk stratification through the analysis of DNA methylation profiles in the oral epithelium may be a useful and less invasive first-step approach in an efficient two-step lung cancer screening strategy.

Keywords

Biomarkers tumor DNA methylation Early detection of cancer Lung neoplasms Mouth mucosa Smoking

Get full access to this article

View all access options for this article.

References

Ferlay

Soerjomataram

Dikshit

et al . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–E386.

Aberle

Adams

Berg

et al . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395–409.

Aberle

DeMello

Berg

et al . Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013; 369: 920–931.

Mikeska

Bock

and Dobrovic

DNA methylation biomarkers in cancer: progress towards clinical implementation.

Expert Rev Mol Diagn 2012; 12: 473–487.

Yang

Kuang

et al . Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules. Onco Targets Ther 2017; 10: 5915–5926.

Farlow

Patel

Basu

et al . Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 2010; 16: 3452–3462.

Wang

et al . Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PLoS One 2013; 8: e78070.

Chen

Shen

et al . Serum lipidomics profiling to identify biomarkers for non-small cell lung cancer. BioMed Research Int 2018 Aug 7; 2018: 5276240.

Herman

and Baylin

SB.

Gene silencing in cancer in association with promoter hypermethylation.

N Engl J Med 2003; 349: 2042–2054.

10.

Jones

and Baylin

SB.

The fundamental role of epigenetic events in cancer.

Nat Rev Genet 2002; 3: 415–428.

11.

Watanabe

Kim

Castoro

et al . Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 2009; 136: 2149–2158.

12.

Maekita

Nakazawa

Mihara

et al . High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989–995.

13.

Kisiel

Yab

Taylor

et al . Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer 2012; 118: 2623–2631.

14.

Ahlquist

Zou

Domanico

et al . Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012; 142: 248–256.

15.

Harada

Miyamoto

, Yamashita, et al. Implication of DNA methylation profiling in oral epithelium for lung cancer screening. ISRN Pulmonol 2012; article ID 973203. doi:10.5402/2012/973203.

16.

Miyamoto

Asada

Fukutomi

et al . Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 2003; 22: 274–280.

17.

Miyamoto

Fukutomi

Akashi-Tanaka

et al . Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 2005; 116: 407–414.

18.

Radosevich

Mutyal

Rogers

et al . Buccal spectral markers for lung cancer risk stratification. PLoS One 2014; 9: e110157.

19.

Bach

Silvestri

Hanger

Jett

and American College of Chest Physicians. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 69S–77S.

20.

Baylin

Herman

Graff

et al . Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–196.

21.

Bhutani

Pathak

Fan

et al . Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 2008; 1: 39–44.